DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Market Segmentation

• By Drug Type (Revenue, USD Bn, 2021-2033)

  • Synthetic (sDMARD)
    • Conventional synthetic (csDMARDs)
      • Methotrexate
      • Sulfasalazine
      • Leflunomide
      • Hydroxychloroquine
      • Gold Salts
  • Targeted synthetic DMARDs (tsDMARDs)
  • Biological DMARDs (bDMARD)
    • Original DMARDs (boDMARDs)
    • Biosimilar DMARDs (bsDMARDs)
    • Primary
    • Secondary
    • Tertiary
  • Others

• By Route of Administration (Revenue, USD Bn, 2021-2033)

  • Oral
  • Parenteral
  • Others

• By Indication (Revenue, USD Bn, 2021-2033)

  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Systemic Lupus Erythematosus
  • Others

• By Distribution Channel (Revenue, USD Bn, 2021-2033)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

• Global Disease-Modifying Antirheumatic Drug (DMARD) Market, By Region (Revenue, USD Bn, 2021-2033)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa